Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price traded down 10.8% during trading on Monday . The company traded as low as GBX 1.69 and last traded at GBX 1.69. 350,297 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 1,338,121 shares. The stock had previously closed at GBX 1.90.
Cizzle Biotechnology Stock Down 10.8%
The company has a 50-day simple moving average of GBX 1.57 and a two-hundred day simple moving average of GBX 1.58. The stock has a market cap of £6.71 million, a P/E ratio of -5.29 and a beta of 0.38.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last issued its earnings results on Tuesday, September 30th. The company reported GBX (0.09) earnings per share (EPS) for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- ESG Stocks, What Investors Should Know
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- Should You Invest in Penny Stocks?
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- What is diluted earnings per share (Diluted EPS)?
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
